News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

John Swen

Advertisement

Articles by John Swen

i1_t-695704-1408636064828.gif

Specialty Care Medicines: Managing the Impact of US Health Reform

ByJohn Swen
November 1st 2010

There's been much talk of how US health reform will impact physicians, patients, and insurance companies. But how will it affect the often overlooked specialty drug market?

Advertisement

Latest Updated Articles

  • i1_t-695704-1408636064828.gif
    Specialty Care Medicines: Managing the Impact of US Health Reform

    November 1st 2010



Advertisement
Advertisement

Trending on PharmExec

1

Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees

2

Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty

3

Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers

4

Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report

5

Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us